Does testosterone therapy cause hair loss?

It does not cause it, but it can accelerate it in men who are genetically susceptible. Therapy raises the testosterone available for conversion into DHT, and DHT is what drives miniaturization in follicles carrying the inherited sensitivity. A man without that sensitivity can run therapy for a decade and keep everything. A man with it was likely going to lose hair regardless, and therapy moves the timeline forward rather than changing the destination.

Will lowering my testosterone dose save my hair?

It slows the process rather than stopping it, and only in proportion to how much substrate you remove. Men who lose hair after a dose increase sometimes stabilize by going back down, which is worth knowing. The problem is that most men chose their dose because of how it made them feel, and giving that back to slow a process that still continues is a poor trade for many. It is a legitimate option, just rarely a complete solution on its own.

How long after starting therapy would hair loss show up?

Most men who notice a change report it somewhere between three and six months in, which reflects the length of a hair cycle rather than anything dramatic happening at that point. Some see an early shed in the first two months as follicles synchronize, and that shed often resolves. This is exactly why standardized photographs matter, because distinguishing a temporary shed from real progressive thinning is genuinely difficult from memory.

Does finasteride lower testosterone?

No, and it often does the opposite by a small margin. Blocking 5-alpha reductase means less testosterone gets converted into DHT, so total testosterone tends to sit flat or drift slightly upward. What falls is serum DHT, typically by around seventy percent on a standard oral dose. Men who feel worse on it are generally responding to the loss of DHT itself rather than to any drop in testosterone, which is a real distinction when interpreting a panel that looks fine.

Is topical finasteride safer than oral?

It produces less systemic DHT suppression at comparable scalp effect in the available studies, which is the argument for it. Less is not none. Absorption still happens, serum DHT still falls, and men who are sensitive to DHT suppression can still notice it. Formulations also vary substantially between compounding pharmacies, so results with one product do not predict results with another. It is a reasonable middle option rather than a way to get the benefit without the mechanism.

Can I regrow hair I already lost?

Partially, and only where the follicle is miniaturized rather than gone. Thinner hairs that are still cycling can thicken again, which is why men sometimes see modest improvement in the first year of treatment. A follicle that stopped producing entirely and scarred over does not come back with any medication currently available. This is the core reason timing dominates the decision, since every month of delay converts recoverable follicles into permanent ones.

Do DHT blockers interfere with the benefits of TRT?

For most men, no. Muscle, energy, and body composition responses are driven largely by testosterone acting at the androgen receptor directly, and those are unaffected. Libido is the one that comes up repeatedly, since DHT appears to contribute more to sexual function than blood testosterone alone suggests. Some men on inhibitors report reduced drive despite excellent panels. If that happens, the panel is not the place to look for the explanation.

Should I check my DHT levels on therapy?

It is informative but rarely decisive. Serum DHT tells you how much conversion is happening systemically, which is useful if you started an inhibitor and want confirmation it is working. It does not tell you what your scalp follicles are doing, because local receptor sensitivity is the variable that matters and no blood test measures it. Standardized photographs over twelve months answer the question you actually care about far better than a number does.

testosterone24

DHT and Hair Loss on TRT: What the Conversion Actually Does

Back to Articles

Hormones 13 min read Aug 10, 2026

DHT and Hair Loss on TRT: What the Conversion Actually Does

The side effect men worry about most, explained by the enzyme rather than the hormone.

A man starts therapy, feels better than he has in a decade, and four months later sees his hairline in a photograph he was not looking at his hairline in. The obvious conclusion is that the injections did it. The more accurate version is that they raised the supply of a raw material his follicles were already sensitive to, and that sensitivity was decided long before he filled a prescription.

Dihydrotestosterone, called DHT everywhere except on a lab report, is what testosterone becomes when it meets an enzyme called 5-alpha reductase. The conversion happens in skin, in the prostate, in the scalp, and anywhere else the body wants an androgen signal stronger than testosterone alone can produce. DHT binds the androgen receptor several times more tightly than testosterone does, which is why a small quantity of it accomplishes a large amount of work. In a follicle carrying the inherited sensitivity, that same strength is the whole problem.

Raise circulating testosterone and you raise the substrate available for that conversion, so serum DHT climbs too. This is the mechanism behind the fear, and the fear is not unfounded. What gets lost is that the hormone is not the deciding factor. Men with identical DHT levels end up with completely different heads of hair, because what varies between them is not the amount of signal in the blood but how loudly the receptor in the scalp responds to it.

~5x

Receptor Affinity

approximate binding strength of DHT compared with testosterone at the androgen receptor

2-3x

Serum DHT Rise

commonly reported increase after starting standard testosterone therapy

~70%

Scalp Enzyme Share

portion of scalp conversion generally attributed to the type 2 isoenzyme

3-6 mo

Notice Window

when men most often report seeing change after a protocol shift

The Conversion Is Not the Villain

DHT is the reason a male fetus develops male genitalia. It drives body hair, contributes to sebum production, and does a meaningful share of the androgenic work that men actually want from therapy. Libido in particular seems to lean on it more than the blood testosterone number suggests, which is why some men who crush their DHT feel flat despite a perfect panel. Treating the molecule as pure damage misses that it is doing several jobs, only one of which is unwelcome.

The unwelcome job is miniaturization. In genetically susceptible follicles, DHT binding shortens the growth phase a little more with each cycle. The hair that regrows is thinner, shorter, and lighter than the one before it, until eventually the follicle produces something closer to peach fuzz and then nothing at all. Nobody loses hair overnight. What men perceive as sudden is usually the point at which enough cycles have stacked that the density crosses a visible threshold.

Serum DHT Relative to Personal Baseline by Protocol (Illustrative)

Testosterone alone
Testosterone with topical inhibitor
Testosterone with oral inhibitor

These are illustrative shapes rather than measured values, but the separation between them is the point. Therapy on its own roughly doubles serum DHT and then plateaus. An oral inhibitor pushes it well below where the man started, because it is blocking conversion he was already doing before therapy existed. A topical sits in between by design, since the intent is to act on the scalp while letting more of the systemic conversion continue. Note the shape of the gold line at week four. Suppression is not instant, and neither is anything downstream of it.

The Follicle Is the Variable

If DHT alone determined outcome, every man on therapy would go bald and every man with low testosterone would keep a full head. Neither is true. Plenty of men run high doses for years with an untouched hairline, and plenty of men with clinically low levels are thin on top at thirty. What separates them is receptor density and sensitivity in scalp follicles, which is inherited, unevenly distributed across the head, and not measurable by any test you can order.

What Tends to Decide Hair Outcome on Therapy

Inherited follicle sensitivity
Age and how far miniaturization already ran
Dose and the resulting androgen load
Local scalp enzyme activity
Everything else, including thyroid, iron, and stress

This is a rough weighting of factors rather than a measured breakdown, and the exact proportions would differ between any two men. The useful takeaway is the size of the first slice against the third. Dose matters, and cutting a dose in half will slow things, but a man with strongly sensitive follicles will lose hair eventually on any dose that makes him feel well. A man without that sensitivity can run a protocol that horrifies his friends and keep everything. The therapy sets the pace. Genetics sets the destination.

There is one practical consequence worth stating plainly. If you were already thinning before therapy, the therapy will usually accelerate what was in progress. If your father and both grandfathers kept their hair into their seventies, the risk conversation is a different conversation. Family history is crude, free, and more predictive than any hormone panel you can buy.

The Options and What Each One Costs

Approach	What It Does	Where It Tends to Fit	Main Limitation
Accept it and do nothing	Lets the process run at whatever pace the genetics dictate	Men who were never attached to their hair or who are already comfortably shaved	Irreversible once the follicle is gone, so the decision has a deadline you cannot see
Oral 5-alpha reductase inhibitor	Blocks conversion systemically, dropping serum DHT well below pre-therapy levels	Men actively losing hair who want the highest chance of holding what remains	Systemic effects including reported changes in libido, mood, and ejaculate volume in a minority
Topical finasteride or dutasteride	Targets scalp conversion with less systemic absorption than an oral dose	Men who want protection but are wary of full body DHT suppression	Absorption still occurs, formulations vary widely, and the evidence base is thinner
Minoxidil, oral or topical	Extends the growth phase and improves follicular blood flow without touching DHT at all	Men who want to keep DHT intact, often stacked with an inhibitor rather than replacing one	Does nothing about the underlying cause, so gains stop when it stops
Lowering the dose or changing the protocol	Reduces the substrate available for conversion in the first place	Men whose loss started sharply after a dose increase and who have symptom room to give back	Often trades away the reason for being on therapy, and slows rather than stops the process

Take the Photographs First

The single most useful thing a man can do before his first injection takes about ninety seconds. Stand under a consistent overhead light and take four photographs: hairline straight on, crown from above, and both temples. Then repeat exactly that every three months in the same spot at the same time of day. Hair loss is invisible to the person living with it because the change per week is smaller than the noise from lighting, wetness, and how you slept on it. Almost every man who insists therapy destroyed his hairline in six weeks is comparing a bad bathroom mirror against a memory. Almost every man who dismisses real thinning for two years is doing the same thing in the other direction. Photographs settle it, and they cost nothing.

Where the Blockers Actually Sit

5-alpha reductase comes in more than one form. The type 2 isoenzyme does most of the work in scalp and prostate tissue, and finasteride primarily inhibits that one. Dutasteride inhibits both type 1 and type 2, which is why it suppresses serum DHT far more completely and why it carries a correspondingly larger footprint. This is the entire difference between the two drugs that men argue about online, and the choice between them is a question of how much suppression you want in exchange for how much systemic exposure.

Approximate Serum DHT Reduction by Intervention (%)

Suppressing DHT does not lower total testosterone, and on therapy it often nudges it slightly upward since less is being converted away
Regrowth is the exception rather than the expectation, and holding current density is what these drugs mostly deliver
An initial shed in the first two to three months is common and is not evidence the drug is making things worse
Nothing works on a follicle that is already gone, which is why the timing of the decision matters more than the choice
A minority of men report persistent sexual or mood effects, and while the frequency is debated, the reports are not nothing
Stopping means losing everything the drug was holding, usually over the following six to twelve months

That fifth point deserves an honest paragraph rather than a bullet. The controversy around persistent side effects from finasteride is genuine and unresolved. Large trials report low rates of sexual side effects and near complete resolution on discontinuation. A visible community of men report otherwise, sometimes years later. Dismissing them is not scientifically defensible, and neither is treating a widely prescribed drug as universally dangerous. What both sides agree on is that the effects, when they occur, appear early. Starting at a low dose or a reduced frequency and paying attention for the first two months is a reasonable way to find out where you fall.

A Sensible Order of Operations

Document the Baseline

Four standardized photographs and an honest look at family history before the first injection rather than after the panic

→

↓

Wait Two Cycles

Give therapy three to six months before concluding anything, since early shedding and real miniaturization look identical at the start

→

↓

Change One Variable

Add a single intervention and hold everything else steady, because stacking three at once tells you nothing about which one worked

→

↓

Judge at Twelve Months

Compare photographs rather than impressions, and expect maintenance rather than reversal as the realistic outcome

The Middle Ground Most Men End Up In

Very few men choose either extreme. The common landing spot is a low or reduced-frequency oral dose, or a topical formulation, paired with minoxidil, on the theory that partial protection with tolerable side effects beats full protection they will quit in four months. Whether that logic holds depends entirely on how aggressive the loss is. A man watching his crown disappear at thirty five is in a different situation from one whose temples have crept back a centimeter since his forties.

Reduced frequency oral dosing appeals to men who want systemic suppression without daily exposure, though the evidence for equivalence is limited
Topical formulations differ enormously between compounding pharmacies, so results are not portable from one product to another
Minoxidil pairs well with an inhibitor because the two work on separate mechanisms rather than duplicating each other
Ketoconazole shampoo appears in most stacks and is the lowest-effort addition, though its contribution is modest
Microneedling has reasonable supporting evidence as an adjunct and none at all as a standalone approach
A transplant moves resistant follicles rather than protecting susceptible ones, so most surgeons want the loss stabilized first

Tracking Something That Moves in Years

The hardest part of managing this is that the feedback loop is slower than human patience. A hair cycle runs for years. An intervention needs six months before it has said anything and twelve before the answer is reliable. Men abandon working protocols at month four constantly, because month four is when the initial shed has happened and nothing has visibly improved yet. Building the monitoring in advance is the only defense against your own impatience.

Twelve Months of Watching a Slow Variable

Before Starting Therapy

✓Take the four standardized photographs under consistent overhead lighting and store them somewhere you will find them
✓Ask about hair on both sides of the family, since the maternal-only inheritance idea is an oversimplification
✓Note any existing thinning honestly, because therapy accelerates what is in progress rather than starting something new
✓Decide in advance what result would make you act, so the decision is not made in a bad moment in front of a mirror

Months 1 to 6

✓Repeat the photographs at month three and month six in the same spot with the same lighting
✓Expect some shedding in the first months from the therapy itself, which is not the same as permanent loss
✓Hold the testosterone protocol steady so any change can be attributed to one variable rather than several
✓If loss is clearly accelerating by month six, this is the point to raise it rather than the point to wait longer

Months 7 to 12 and Beyond

✓Compare month twelve photographs against baseline directly, without relying on how you think it looked in spring
✓If an intervention was added, evaluate it on maintenance rather than regrowth, since holding ground is the usual win
✓Recheck total and free testosterone if you started an inhibitor, as less conversion can shift the numbers slightly
✓Once stable, keep photographing annually, because the process continues quietly whether or not you are watching it

One last framing. The men who handle this best are the ones who decided early what they wanted, either committing to protection while there was something to protect or accepting the outcome and moving on. The worst position is three years of low grade worry, no photographs, no intervention, and a hairline that quietly went somewhere while nobody was measuring. That is not a hormonal problem. It is a decision that never got made.

Medical Disclaimer

This article is for educational purposes only and is not medical advice. Nothing here diagnoses, treats, cures, or prevents any disease. Finasteride, dutasteride, and testosterone are prescription medications in most jurisdictions and their use requires evaluation and supervision by a licensed physician. The values shown in the charts are illustrative demonstrations of relationships between variables and are not study results, clinical recommendations, or predictions about any individual outcome. Suppression percentages are included to show how far apart the available options sit and must not be used as guidance. Hair loss has causes unrelated to androgens, including thyroid disease, iron deficiency, and autoimmune conditions, all of which require proper medical evaluation. Do not start, stop, or change any hormone therapy, medication, or dose on the basis of this article. Speak with a licensed physician about your symptoms, your bloodwork, and your medical history before making any decision.